recombinant H5N1 vaccine (Tetragenetics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant H5N1 vaccine (Tetragenetics)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTetragenetics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTetragenetics

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A